CIM INVESTMENT MANAGEMENT INC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
CIM INVESTMENT MANAGEMENT INC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$305,256
+5.9%
7,9910.0%0.11%
+14.3%
Q2 2023$288,235
+43.6%
7,991
+52.1%
0.10%
+32.4%
Q1 2023$200,688
-34.6%
5,255
-32.4%
0.07%
-45.6%
Q3 2022$307,000
+12.5%
7,769
+25.3%
0.14%
+20.4%
Q2 2022$273,000
+33.8%
6,199
+21.4%
0.11%
+63.8%
Q1 2022$204,000
-11.3%
5,108
-10.6%
0.07%0.0%
Q4 2021$230,000
-0.9%
5,7120.0%0.07%
-5.5%
Q3 2021$232,000
-10.4%
5,7120.0%0.07%
-8.8%
Q2 2021$259,000
+8.8%
5,7120.0%0.08%
+6.7%
Q1 2021$238,0005,7120.08%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders